Health Care & Life Sciences » Pharmaceuticals | WooGene B&G Co. Ltd.

WooGene B&G Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
606
821
353
175
4,190
Depreciation, Depletion & Amortization
754
864
867
882
1,496
Other Funds
83
342
286
242
1,095
Funds from Operations
1,443
2,027
934
1,299
1,599
Changes in Working Capital
1,079
546
2,503
1,529
59
Net Operating Cash Flow
365
1,482
1,569
2,828
1,540
Capital Expenditures
1,377
2,383
9,141
14,508
8,898
Sale of Fixed Assets & Businesses
-
-
5
19
1
Purchase/Sale of Investments
122
301
149
532
363
Net Investing Cash Flow
1,499
2,082
9,241
14,002
8,524
Cash Dividends Paid - Total
-
-
191
-
-
Issuance/Reduction of Debt, Net
777
303
12,736
14,492
4,720
Net Financing Cash Flow
799
948
13,545
14,490
4,716
Net Change in Cash
342
358
2,734
3,335
5,368
Free Cash Flow
994
898
10,709
10,969
10,194
Other Sources
-
-
43
5
36
Change in Capital Stock
22
1,251
1,000
3
4
Exchange Rate Effect
6
10
-
19
20
Other Uses
-
-
-
50
26

About WooGene B&G Co.

View Profile
Address
230 Jeongmunsongsan-ro
Hwaseong GY 18629
Korea, Republic Of
Employees -
Website http://www.woogenebng.com
Updated 09/14/2018
WooGene B&G Co., Ltd. manufactures and sells veterinary pharmaceutical and nutraceutical products. It operates through the following divisions: Pharmaceuticals and Nutraceuticals. The Pharmaceutical division's products include anti-infective drugs, probiotics, anti-parasitics, hormone preparations, vaccines, anesthetics, teat dips, disinfectants, pet cure drugs, calcium injections, sedative injections, toxin binders and bacterial disease remedies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.